Country Profile
Hong Kong is a growing market for Indian pharmaceuticals — $47.1M in FY 2025–26. Medicines accounts for 73% of shipments, with vaccines contributing $297K.
No recorded pharmaceutical sector investment transactions from Indian companies to Hong Kong in the RBI overseas direct investment dataset (2011–2026).